Compare WST & DECK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WST | DECK |
|---|---|---|
| Founded | 1923 | 1973 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Shoe Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.7B | 12.4B |
| IPO Year | 2004 | 1996 |
| Metric | WST | DECK |
|---|---|---|
| Price | $398.29 | $79.71 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 16 | 27 |
| Target Price | ★ $416.40 | $96.74 |
| AVG Volume (30 Days) | 460.9K | ★ 3.1M |
| Earning Date | 10-29-2026 | 10-22-2026 |
| Dividend Yield | ★ 0.26% | N/A |
| EPS Growth | 1.49 | ★ 10.90 |
| EPS | ★ 4.07 | 0.94 |
| Revenue | $2,886,900,000.00 | ★ $5,472,296,000.00 |
| Revenue This Year | $9.78 | $4.33 |
| Revenue Next Year | $6.30 | $5.81 |
| P/E Ratio | $97.62 | ★ $85.53 |
| Revenue Growth | 1.95 | ★ 9.76 |
| 52 Week Low | $223.83 | $77.37 |
| 52 Week High | $398.38 | $122.29 |
| Indicator | WST | DECK |
|---|---|---|
| Relative Strength Index (RSI) | N/A | N/A |
| Support Level | N/A | N/A |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.00 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 0.00 |
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
Founded in 1973, California-based Deckers designs and sells casual and performance footwear, apparel, and accessories. In fiscal 2026, Ugg and Hoka accounted for 50% and 47% of total sales, respectively. The firm also markets a niche sandal brand Teva. Deckers produces most of its sales through wholesale partnerships but also operates e-commerce in more than 50 countries and has more than 200 company-operated stores, about half of which are outlets. The firm generated 58% of its fiscal 2026 sales in the United States.